Literature DB >> 19577382

Mixed ovarian large cell neuroendocrine carcinoma, mucinous adenocarcinoma, and teratoma: a report of two cases and review of the literature.

Jacinthe Chênevert1, Paul Bessette, Marie Plante, Bernard Têtu, Valérie Dubé.   

Abstract

Large cell neuroendocrine carcinoma of the ovary is a rare recently established entity. Few cases have been reported in the literature, and they are usually associated with another type of surface epithelial tumor. The association of a large cell neuroendocrine carcinoma with a surface epithelial tumor and a teratoma is even rarer, with only two cases previously described. We report the cases of two patients in their fifties who presented with a growing abdominal mass and died of metastatic disease within less than a year. Histological assessment revealed large cell neuroendocrine carcinoma admixed with mucinous adenocarcinoma and teratoma. Different hypotheses regarding the origin of large cell neuroendocrine carcinoma of the ovary are discussed. The immunohistochemical pattern of staining for cytokeratin 7 and cytokeratin 20 suggests that the composite epithelial tumors originated from the pre-existing teratoma.

Entities:  

Mesh:

Year:  2009        PMID: 19577382     DOI: 10.1016/j.prp.2009.01.013

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  Pure Large Cell Neuroendocrine Carcinoma of the Ovary with Metastasis to Cervix: A Rare Case Report and Review of Literature.

Authors:  Lakshmi Agarwal; Bhawna Gupta; Ayushi Jain
Journal:  J Clin Diagn Res       Date:  2016-09-01

2.  Large Cell Neuroendocrine Carcinoma of the Ovary and Its Skin Metastases: A Case Report and Review of the Literature.

Authors:  S Cokmert; L Demir; L Doganay; N Demir; K Kocacelebi; I T Unek; E Gezer; K Kilic; M Alakavuklar
Journal:  West Indian Med J       Date:  2014-07-03       Impact factor: 0.171

3.  Differences in Characteristics and Outcomes Between Large-Cell Neuroendocrine Carcinoma of the Ovary and High-Grade Serous Ovarian Cancer: A Retrospective Observational Cohort Study.

Authors:  Li Pang; Zhiqiang Guo
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

4.  Malignant mixed epithelial tumour of ovary-serous papillary cystadenocarcinoma and transitional cell carcinoma with tubo-ovarian torsion: a rare tumour with rare presentation.

Authors:  Shashikant Adlekha; Tandra Chadha
Journal:  Malays J Med Sci       Date:  2013-10

Review 5.  Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature.

Authors:  Eun Young Ki; Jong Sup Park; Keun Ho Lee; Seog Nyeon Bae; Soo Young Hur
Journal:  World J Surg Oncol       Date:  2014-10-15       Impact factor: 2.754

6.  Role of diagnostic laparoscopy in patients with large cell neuroendocrine carcinoma of the ovary with cancerous peritonitis: case report and review of the literature.

Authors:  Hideaki Tsuyoshi; Kenji Yashiro; Shizuka Yamada; Makoto Yamamoto; Toshimichi Onuma; Tetsuji Kurokawa; Yoshio Yoshida
Journal:  J Ovarian Res       Date:  2019-10-15       Impact factor: 4.234

7.  An Ovarian Large-Cell Neuroendocrine Carcinoma Accompanied by Clear Cell Carcinoma with Specific High Level of AFP: Case Report and Review of the Literature.

Authors:  Jian Qiu; Jiewei Xu; Guorong Yao; Fengjia Zhu; Yanyan Wang; Yunfeng Fu
Journal:  Cancer Manag Res       Date:  2022-07-22       Impact factor: 3.602

Review 8.  Gynecologic large cell neuroendocrine carcinoma: A review.

Authors:  Grant Burkeen; Aman Chauhan; Rohitashva Agrawal; Riva Raiker; Jill Kolesar; Lowell Anthony; B Mark Evers; Susanne Arnold
Journal:  Rare Tumors       Date:  2020-10-29

Review 9.  Emerging Therapeutic Concepts and Latest Diagnostic Advancements Regarding Neuroendocrine Tumors of the Gynecologic Tract.

Authors:  Tiberiu-Augustin Georgescu; Roxana Elena Bohiltea; Octavian Munteanu; Florentina Furtunescu; Antonia-Carmen Lisievici; Corina Grigoriu; Florentina Gherghiceanu; Emilia Maria Vlădăreanu; Costin Berceanu; Ionita Ducu; Ana-Maria Iordache
Journal:  Medicina (Kaunas)       Date:  2021-12-07       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.